Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ANI PHARMACEUTICALS INC Director's Dealing 2014

Feb 14, 2014

31676_dirs_2014-02-14_7698f81e-c050-4cef-9f9b-c6d5ed26d9be.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2013-07-12

Reporting Person: Marken James G. (Vice President, Operations)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Option to Purchase $ Common Stock (0) 0 Direct

Footnotes

F1: On July 16, 2013, the reporting person filed a Form 4 in error that reported the grant of an option to purchase 177,500 shares of common stock conditioned upon shareholder approval of an amendment to the Issuer's 2008 Stock Incentive Plan to increase the number of shares authorized for issuance under the Plan. This amendment is being filed to correct the report of the conditional grant made on July 12, 2013. The grant will be reported following such shareholder approval, if obtained.